Cargando…
Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
Molecular and metabolic alterations in cancer cells are one of the leading causes of acquired resistance to chemotherapeutics. In this study, we explored an experimental strategy to identify which of these alterations can induce erlotinib resistance in human pancreatic cancer. Using genetically matc...
Autores principales: | Jang, Won-Jun, Choi, Boyeon, Song, Sang-Hoon, Lee, Naeun, Kim, Dong-Joon, Lee, Sooyeun, Jeong, Chul-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696217/ https://www.ncbi.nlm.nih.gov/pubmed/29190951 http://dx.doi.org/10.18632/oncotarget.21572 |
Ejemplares similares
-
Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance
por: Lee, Sooyeun, et al.
Publicado: (2017) -
Chloroform induction of ornithine decarboxylase activity in rats.
por: Savage, R E, et al.
Publicado: (1982) -
Downregulation of tumstatin expression by overexpression of ornithine decarboxylase
por: WANG, WEI, et al.
Publicado: (2013) -
Metabolic Characterization of Hyoscyamus niger Ornithine Decarboxylase
por: Zhao, Tengfei, et al.
Publicado: (2019) -
A safety catch for ornithine decarboxylase degradation
por: Taxis, Christof
Publicado: (2015)